Optum moves forward in $3.3B deal: What ASCs need to know

By Becker's ASC in ASC Transactions and Valuation Issues, Becker's ASC Review, Channels, Featured, ROOT
September 27, 2023

Earlier this month, Amedisys shareholders approved a $3.3 billion acquisition by Optum.

Read the full post on Becker's ASC

Becker's ASC